The practice of retina is rapidly evolving as newer and better therapeutics become available. The flurry of research on macular disease is spawning new drugs and new treatment protocols. Through our newsletter, we provide updates on the new developments in our practice and in the field of retina, including new clinical trials as they emerge. As always, our goal remains to provide the best possible retinal care and to communicate our findings and plans to our referring doctors expediently. We hope that you find our little missive informative and useful.